Caregen케어젠
214370 · KOSDAQ · ₩214370 · 케어젠
₩34,350▲ ₩1,050 (3.15%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 1, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 29, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 28, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 23, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 31, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 29, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 10, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 8, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정 (중간배당)Jul 3, 2026Open on DART
- Designation as Unfaithful Disclosure Company (1 case of disclosure reversal, 1 case of disclosure modification)불성실공시법인지정 (공시번복 1건, 공시변경 1건)Jun 29, 2026Open on DART
- Notice of Designation as Unfaithful Disclosure Entity (1 disclosure reversal, 1 disclosure change)불성실공시법인지정예고 (공시번복 1건, 공시변경 1건)Jun 17, 2026Open on DART
- Decision on Shareholder Register Closure (Record Date) for Interim (Quarterly) Dividend중간(분기)배당을위한주주명부폐쇄(기준일)결정Jun 12, 2026Open on DART
- Sales or supply contract terminated단일판매ㆍ공급계약해지(자율공시)May 29, 2026Open on DART
- Sales or supply contract terminated단일판매ㆍ공급계약해지May 29, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 27, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)May 21, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 13, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Apr 30, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 28, 2026Open on DART
- Advance Notice of Earnings Results Disclosure결산실적공시예고Apr 24, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 24, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 24, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 22, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 31, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 31, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Mar 25, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 25, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 24, 2026Open on DART
- Corporate value-up plan기업가치제고계획(자율공시)Mar 24, 2026Open on DART
- Audit report submitted감사보고서제출Mar 16, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 16, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Mar 13, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Mar 9, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 9, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 9, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 9, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Feb 23, 2026Open on DART
- Other management matters기타경영사항(자율공시) (코글루타이드 (Korglutide), 미국식품의약국(USFDA)으로부터 NDI(New Dietary Ingredients) 로 승인)Jan 30, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 20, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Dec 31, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (CG-P5 펩타이드 기반 신약 후보물질의 제1상 임상시험 결과 수령)Dec 30, 2025Open on DART
- Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Dec 12, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (CGP5 펩타이드 기반 신약 후보물질의 제1상 임상시험계획(IND) 승인)Dec 1, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (CGP5 펩타이드 기반 신약 후보물질의 제1상 임상시험계획(IND) 승인)Oct 24, 2025Open on DART
- Change of Head Office Location본점소재지변경Sep 23, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Caregen / 케어젠 / 214370 / KRX:214370
Source: KRX statistical information